Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

World’s most populous country gains access to Medtronic’s newest TAVR valve
Medtronic developed the self-expanding Evolut FX+ TAVR system with improved coronary access in mind. The FDA-approved device has now officially launched in India.
New registry helps hospitals expand outpatient services for heart patients
The initiation of the ACC Ambulatory Surgical Center Registry comes at a time when hospitals are expanding their structural heart programs. The registry is providing valuable details about which patients should stay at the hospital and which can be treated in an outpatient setting.
FDA highlights risks of evaluating blood pressure with unauthorized medical devices
The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.
Joysticks recalled after power wheelchairs move on their own, injuring a patient
The U.S. Food and Drug Administration announced a recall of Mo-Vis BVBA joysticks after a faulty firmware version was linked to the malfunction. Users will need to have their devices upgraded.
FDA approves nasal spray for edema associated with congestive heart failure
The newly approved intranasal loop diuretic can also be used to treat edema in patients with liver and kidney disease.

New study of more than 4.5M patients examines how blood pressure can impact the risk of dementia

Researchers said they hope their findings can shine new light on this "complex relationship."

PAD specialists announce new FDA clearance for image-guided atherectomy system

The solution is now cleared as a treatment option for in-stent restenosis in the lower extremity arteries.

Pfizer formally submits COVID-19 pill to FDA for emergency use authorization

An initial analysis revealed Paxlovid reduced the risk of hospitalization or death in high-risk patients who took the pill within 3 days of experiencing symptoms.

Patient frailty not a key factor when choosing between TAVR and SAVR

Frailty measurements may still provide helpful information in other ways, of course.

PCI and CABG for left main CAD associated with similar all-cause mortality rates

Researchers examined data from the SYNTAX, PRECOMBAT, NOBLE and EXCEL trials, sharing their findings in The Lancet.

What new research tells us about TAVR and platelet-to-lymphocyte ratios

The blood-based biomarker was previously associated with worse acute coronary syndrome outcomes. What does it mean for TAVR patients?

40% of providers plan to keep COVID-19 protocols in place post-pandemic

Additionally, 71% of medical professionals said safety standards increased during the health crisis.

Stem cell therapy for heart failure lowers risk of adverse outcomes

“Cell therapy has the potential to change how we treat heart failure,” one researcher said.

Clinical

World’s most populous country gains access to Medtronic’s newest TAVR valve

New registry helps hospitals expand outpatient services for heart patients

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

Joysticks recalled after power wheelchairs move on their own, injuring a patient

FDA approves nasal spray for edema associated with congestive heart failure